glycine has been researched along with Cardiomyopathy, Hypertrophic in 8 studies
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L | 1 |
| Wang, B | 1 |
| Zhang, F | 1 |
| Gao, C | 1 |
| Hu, G | 1 |
| Zhou, M | 1 |
| Wang, R | 1 |
| Zhao, H | 1 |
| Yan, W | 1 |
| Zhang, L | 1 |
| Ma, Z | 1 |
| Yang, W | 1 |
| Guo, X | 1 |
| Huang, C | 1 |
| Cui, Z | 1 |
| Sun, F | 1 |
| Song, D | 1 |
| Liu, L | 1 |
| Tao, L | 1 |
| Rysev, NA | 1 |
| Karpicheva, OE | 1 |
| Redwood, CS | 2 |
| Borovikov, YS | 1 |
| Li, XE | 1 |
| Suphamungmee, W | 1 |
| Janco, M | 1 |
| Geeves, MA | 1 |
| Marston, SB | 2 |
| Fischer, S | 1 |
| Lehman, W | 1 |
| Arai, S | 1 |
| Matsuoka, R | 1 |
| Hirayama, K | 1 |
| Sakurai, H | 1 |
| Tamura, M | 1 |
| Ozawa, T | 1 |
| Kimura, M | 1 |
| Imamura, S | 1 |
| Furutani, Y | 1 |
| Joh-o, K | 1 |
| Kimura, A | 1 |
| Harada, H | 1 |
| Park, JE | 1 |
| Nishi, H | 1 |
| Satoh, M | 1 |
| Takahashi, M | 1 |
| Hiroi, S | 1 |
| Sasaoka, T | 1 |
| Ohbuchi, N | 1 |
| Nakamura, T | 1 |
| Koyanagi, T | 1 |
| Hwang, TH | 1 |
| Choo, JA | 1 |
| Chung, KS | 1 |
| Hasegawa, A | 1 |
| Nagai, R | 1 |
| Okazaki, O | 1 |
| Nakamura, H | 1 |
| Matsuzaki, M | 1 |
| Sakamoto, T | 1 |
| Toshima, H | 1 |
| Koga, Y | 1 |
| Imaizumi, T | 1 |
| Sasazuki, T | 1 |
| Bing, W | 1 |
| Purcell, IF | 1 |
| Esposito, G | 1 |
| Watkins, H | 1 |
| Raha, S | 1 |
| Merante, F | 1 |
| Shoubridge, E | 1 |
| Myint, AT | 1 |
| Tein, I | 1 |
| Benson, L | 1 |
| Johns, T | 1 |
| Robinson, BH | 1 |
| Takahashi-Yanaga, F | 1 |
| Morimoto, S | 1 |
| Ohtsuki, I | 1 |
8 other studies available for glycine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Novel biomarkers identifying hypertrophic cardiomyopathy and its obstructive variant based on targeted amino acid metabolomics.
Topics: Amino Acids; Arginine; Biomarkers; Cardiomyopathy, Hypertrophic; Choline; Cysteine; Glycine; Humans; | 2022 |
The effect of the Asp175Asn and Glu180Gly TPM1 mutations on actin-myosin interaction during the ATPase cycle.
Topics: Actins; Actomyosin; Adenosine Triphosphatases; Amino Acid Substitution; Animals; Asparagine; Asparti | 2012 |
The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy.
Topics: Actins; Amino Acid Substitution; Asparagine; Aspartic Acid; Calcium; Cardiomyopathy, Hypertrophic; G | 2012 |
Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Aged; Base Sequence; Cardiomyopathy, Hypertrophic; Child, Preschool; DNA Primers; | 1995 |
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.
Topics: Actins; Amino Acid Sequence; Animals; Arginine; Base Sequence; Cardiomyopathy, Hypertrophic; Carrier | 1997 |
Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.
Topics: Actins; Animals; Asparagine; Aspartic Acid; Cardiomyopathy, Hypertrophic; Glutamic Acid; Glycine; Mu | 1997 |
Repopulation of rho0 cells with mitochondria from a patient with a mitochondrial DNA point mutation in tRNA(Gly) results in respiratory chain dysfunction.
Topics: Blotting, Southern; Cardiomyopathy, Hypertrophic; Citrate (si)-Synthase; DNA, Mitochondrial; Electro | 1999 |
Effect of Arg145Gly mutation in human cardiac troponin I on the ATPase activity of cardiac myofibrils.
Topics: Adenosine Triphosphatases; Animals; Arginine; Cardiomyopathy, Hypertrophic; DNA, Complementary; Dose | 2000 |